ADRES Int'l Biotech Consultation & Execution

ADRES Int'l Biotech Consultation & Execution is a leading biotechnology research firm committed to illuminating the path from therapeutic concept to market. With over three decades of experience collaborating with the FDA and other leading regulatory bodies worldwide, ADRES Int'l Biotech Consultation & Execution provides comprehensive regulatory affairs, quality assurance (QA), and CMC consulting services. Their expertise spans across the United States, Europe, Brazil, India, China, and Israel, catering to a diverse clientele from early-stage startups to established pharmaceutical giants.

Located at 2 Yitzhak Modai St., Rehovot, 7608804, IL, and with an additional office at Pietersbergweg 283, Amsterdam, North Holland 1105, NL, ADRES Int'l Biotech Consultation & Execution excels in various pharmaceutical fields, including vaccines, biologicals, cell therapies, ATMPs, botanical drugs, liposomes, and medical devices. They are dedicated to advancing treatments for an array of medical conditions, offering a one-stop-shop solution tailored to meet every client's needs from early R&D phases through development, production, and market launch.

ADRES Int'l Biotech Consultation & Execution ensures the highest standards of strategy and implementation, building strategies that translate to success. Their extensive experience allows them to predict possible obstacles and tailor services to meet current and future needs. ADRES Int'l Biotech Consultation & Execution is dedicated to assisting companies in achieving successful results in line with the highest regulatory standards. The information will be completed soon with the support of the company’s management. We invite the manager of ADRES Int'l Biotech Consultation & Execution to create a customized and exclusive company showcase and product listing on our platform.